You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Primary Myelofibrosis

Showing 51 - 75 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)

Active, not recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 10, 2023

Primary Myelofibrosis, Secondary Myelofibrosis, Myeloid Malignancies Trial in Rochester (Imetelstat)

Completed
Has Results
  • Primary Myelofibrosis
  • +2 more
  • Rochester, Minnesota
    (unnamed)
Aug 24, 2021

Polycythemia Vera, Essential Thrombocythemia, and

Not yet recruiting
  • Myeloproliferative Neoplasm
  • Next-generation sequencing
  • (no location specified)
Jun 27, 2022

Primary Myelofibrosis, Prefibrotic Stage, Myelofibrosis Trial in Hong Kong (Ropeginterferon alfa-2b)

Recruiting
  • Primary Myelofibrosis, Prefibrotic Stage
  • Myelofibrosis
  • Ropeginterferon alfa-2b
  • Hong Kong, Hong Kong
    Department of Medicine, the University of Hong Kong, Queen Mary
Jul 25, 2021

Myelofibrosis Trial in Coral Gables, Tampa, New York (Imetelstat, Ruxolitinib)

Recruiting
  • Myelofibrosis
  • Coral Gables, Florida
  • +2 more
Jul 12, 2022

Myelofibrosis Trial in Houston (CK0804)

Not yet recruiting
  • Myelofibrosis
  • Houston, Texas
    The University of Texas MD Anderson Cancer Center
Jun 28, 2022

Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis

Recruiting
  • Myelofibrosis
  • Hematopoietic Stem Cell Transplant
  • Minneapolis, Minnesota
    Center for International Blood and Marrow Transplant Research
Mar 17, 2022

A Prospective, Two-arm, Non-interventional Study of JAKAVI® in

Active, not recruiting
  • Primary Myelofibrosis
  • +2 more
  • Jakavi
  • Aachen, Germany
    Novartis Investigative Site
Sep 6, 2021

Myelofibrosis, Polycythemia Vera Trial in United States (TGR-1202, ruxolitinib)

Active, not recruiting
  • Myelofibrosis
  • Polycythemia Vera
  • Phoenix, Arizona
  • +4 more
Jun 20, 2022

Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive,

Completed
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +4 more
  • Eltrombopag Olamine
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2022

Myelofibrosis Trial in Worldwide (GB2064)

Recruiting
  • Myelofibrosis
  • Houston, Texas
  • +11 more
Nov 23, 2022

Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)

Recruiting
  • Primary Myelofibrosis
  • Secondary Myelofibrosis
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 21, 2022

Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,

Recruiting
  • Acute Myeloid Leukemia
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Aug 18, 2022

Myelofibrosis, Polycythemia Vera, Thrombocythemia Trial in Worldwide (itacitinib)

Active, not recruiting
  • Myelofibrosis
  • +2 more
  • New Orleans, Louisiana
  • +20 more
Aug 25, 2022

Myelofibrosis Trial in United States (Ruxolitinib, Thalidomide)

Active, not recruiting
  • Myelofibrosis
  • Middletown, New Jersey
  • +6 more
Aug 23, 2022

Myelofibroses Trial in Saint Louis (Pevonedistat, Ruxolitinib, Peripheral blood draw)

Terminated
  • Myelofibroses
  • Saint Louis, Missouri
    Washington University School of Medicine
Dec 16, 2021

Bone Marrow Fibrosis, Myeloproliferative Tumor Trial in Cleveland (Captopril)

Not yet recruiting
  • Bone Marrow Fibrosis
  • Myeloproliferative Neoplasm
  • Cleveland, Ohio
    Cleveland Clinic, Case Comprehensive Cancer Center
Jan 30, 2023

Myelofibrosis, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Tumor Overlap Syndrome Trial in Worldwide

Recruiting
  • Myelofibrosis
  • +5 more
  • Birmingham, Alabama
  • +27 more
Oct 17, 2022

Myelofibrosis Trial in Australia (KER-050 monotherapy, KER-050 in combination with ruxolitinib)

Recruiting
  • Myelofibrosis
  • KER-050 monotherapy
  • KER-050 in combination with ruxolitinib
  • Tweed Heads, New South Wales, Australia
  • +4 more
Mar 2, 2022

MDS, Myeloproliferative Tumors, Myelofibrosis Trial (Jaktinib, azacitidine)

Not yet recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • (no location specified)
Nov 29, 2021

Myelofibrosis Trial in Hangzhou (Jaktinib HCl tablets)

Recruiting
  • Myelofibrosis
  • Jaktinib hydrochloride tablets
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital of Medical School of Zhejiang Univ
Nov 29, 2021

Myelofibrosis Trial in China (TQ05105 Tablets, TQB3617 Capsules)

Not yet recruiting
  • Myelofibrosis
  • TQ05105 Tablets
  • TQB3617 Capsules
  • Guangzhou, Guangdong, China
  • +19 more
Nov 7, 2023

Chronic Myeloid Leukemia, Myelofibroses Trial in Chicago (Azacitidine, Selumetinib)

Recruiting
  • Chronic Myeloid Leukemia
  • Myelofibroses
  • Chicago, Illinois
    The University of Chicago
May 16, 2022

Primary Myelofibrosis Trial (Pacritinib)

Withdrawn
  • Primary Myelofibrosis
  • Pacritinib
  • (no location specified)
May 3, 2021

Primary Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia Trial in Toronto (Observational)

Recruiting
  • Primary Myelofibrosis
  • +9 more
  • Observational
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
Apr 11, 2022